Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Langerhans cell histiocytosis

Langerhans cell histiocytosis

Part of Interstitial Lung Disease

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Langerhans cell histiocytosis

4 trials tracked for Langerhans cell histiocytosis.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4
  1. Phase 2 Stem Cell Transplant for Immunologic or Histiocytic Disorders Completed
  2. Phase 2 Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) Completed
  3. Phase 2 Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma Completed
  4. Phase 2 Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Radiomics features on MRI discriminate sellar LCH from tumor marker-negative GCTs with an AUC of 0.81
Pediatrics Cohort
Radiomics features on MRI discriminate sellar LCH from tumor marker-negative GCTs with an AUC of 0.81 AI Scan Helps Doctors Spot Confusing Brain Tumors
This retrospective cohort study evaluated 93 patients with sellar region tumors to discriminate between Langerhans cell histiocytosis (LCH) …
A new computer system helps doctors tell two similar brain tumors apart using MRI scans.
Frontiers Apr 24, 2026